ORBIMED ADVISORS LLC
10% Owner; Director; Director, 10% Owner · 14 filings · Latest: Jun 22, 2026
Adicet Bio, Inc.
Enliven Therapeutics, Inc.
ImageneBio, Inc.
Prelude Therapeutics Inc
Q32 Bio Inc.
Shattuck Labs, Inc.
Sionna Therapeutics, Inc.
Traws Pharma, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
ACET | ORBIMED ADVISORS LLC | 10% Owner | Apr 8, 2026 | Sale | $6.42 | 72,939 | $468.1K | 0 | |
ACET | ORBIMED ADVISORS LLC | 10% Owner | Apr 7, 2026 | Sale | $6.52 | 31,719 | $206.8K | 32,523 | |
ACET | OrbiMed Genesis Master Fund, L.P. | — | Apr 9, 2026 | Proposed Sale | $6.55 | 78,499 | $514.2K | — | |
KROS | OrbiMed Genesis Master Fund, LP | — | Mar 31, 2026 | Proposed Sale | $11.04 | 45,057 | $497.4K | — | |
SION | ORBIMED ADVISORS LLC | Director | Feb 3, 2026 | Sale | $44.58 | 29,063 | $1.3M | 3,530,702 | |
SION | ORBIMED ADVISORS LLC | Director | Feb 2, 2026 | Sale | $44.57 | 1,890 | $84.2K | 3,559,765 | |
SION | OrbiMed Private Investments VIII, LP | — | Nov 24, 2025 | Proposed Sale | $44.38 | 1,047,770 | $46.5M | — | |
PMVP | OrbiMed Private Investments V, LP | — | Oct 23, 2025 | Proposed Sale | $1.52 | 1,000,000 | $1.5M | — | |
IRON | OrbiMed Private Investments VI, LP | — | Oct 20, 2025 | Proposed Sale | $89.94 | 482,308 | $43.4M | — | |
IRON | OrbiMed Genesis Master Fund, L.P. | — | Oct 20, 2025 | Proposed Sale | $89.94 | 186,541 | $16.8M | — | |
IRON | OrbiMed Private Investments VIII, LP | — | Oct 20, 2025 | Proposed Sale | $89.94 | 746,171 | $67.1M | — | |
PMVP | OrbiMed Private Investments V, LP | — | Sep 10, 2025 | Proposed Sale | $1.60 | 2,283,654 | $3.7M | — | |
PASG | OrbiMed Private Investments VII, LP | — | Jul 21, 2025 | Proposed Sale | $5.56 | 132,645 | $737.5K | — | |
PASG | OrbiMed Private Investments VII, LP | — | Jul 15, 2025 | Proposed Sale | $6.79 | 53,293 | $361.9K | — | |
PASG | OrbiMed Private Investments VII, LP | — | Jul 7, 2025 | Proposed Sale | $0.433 | 259,000 | $112.1K | — | |
PASG | OrbiMed Private Investments VII, LP | — | Jun 24, 2025 | Proposed Sale | $0.3516 | 1,076,120 | $378.4K | — | |
PASG | OrbiMed Private Investments VII, LP | — | Apr 15, 2025 | Proposed Sale | $0.383 | 787,179 | $301.5K | — | |
CMPX | OrbiMed Genesis Master Fund, L.P. | — | Apr 9, 2025 | Proposed Sale | $1.59 | 3,571,428 | $5.7M | — | |
IRON | OrbiMed Genesis Master Fund, L.P. | — | Mar 10, 2025 | Proposed Sale | $55.67 | 74,800 | $4.2M | — | |
IRON | OrbiMed Private Investments VI, LP | — | Mar 10, 2025 | Proposed Sale | $55.67 | 193,400 | $10.8M | — |